A mother’s warning after Ewing sarcoma claimed her son’s life
Joanne McNulty is turning grief into advocacy after the death of her son Callum, who died in 2022 from Ewing sarcoma at the age of 18. His cancer was diagnosed in 2018, and by the time it was discovered, the tumour had attached itself to his spine. The delay left him not only facing chemotherapy, but also months of physiotherapy to relearn how to walk after spinal damage and paralysis.
The story carries a hard clinical lesson for frontline care. Persistent pain in a young person is often attributed to sport, growth, overuse, or a minor injury, yet rare cancers can present in exactly that way. In Callum’s case, back pain triggered four hospital visits before cancer was considered seriously enough to reach a diagnosis.
McNulty said the family kept being reassured because he was active and sporty, and that explanation seemed to fit the symptoms at the time. Looking back, she believes an earlier diagnosis might not have spared him chemotherapy, but it could have prevented the paralysis and the long struggle to walk again.
Back pain in a young person is not automatically benign
Ewing sarcoma is uncommon, but its rarity is part of the danger. When a disease is infrequent, it can be mentally filtered out long before more serious causes are entertained. Dr Elizabet Gomes Dos Santos, a consultant in oncology, said cancer is difficult to diagnose because many symptoms overlap with far more common conditions.
That diagnostic overlap sits at the center of the problem. Pain, nausea, reduced appetite, weight loss, or a child not quite being themselves can be read as temporary or nonspecific. In younger patients, those symptoms often sit alongside a long list of more likely explanations, which makes cancer easy to postpone on the differential diagnosis list until the disease has already progressed.
The spine involvement in Callum’s case shows how quickly a tumour can move from a vague symptom to a structural problem. Once malignant tissue invades or compresses the spinal area, neurologic consequences can follow, including weakness, gait disturbance, and loss of mobility. The need for physiotherapy after diagnosis reflects not just treatment burden but the anatomic cost of delay.
Callum’s mother has repeatedly urged families to push for cancer to be ruled out earlier when symptoms persist. Her message is not about creating fear around every ache or sore back. It is about making sure recurring, unexplained, or changing symptoms in children and young adults are assessed with enough seriousness to avoid missing the uncommon but dangerous diagnoses.
Persistent symptoms in children and teenagers need a wider differential
Dos Santos said the oncology team learned from patient experiences such as Callum’s. Health and Care Jersey recognizes that cancer can affect people of any age, and that children, teenagers, and young adults should not be automatically cleared of concern when symptoms are persistent, unexplained, or worrying. The warning is clinically important because early disease rarely announces itself in a dramatic way.
In practice, this means persistent pain should not be repeatedly dismissed when it continues despite time, reassurance, or ordinary treatment. Weight loss, sickness, and a child who seems less like themselves can be subtle but meaningful clues. The bedside challenge is not that every child with back pain has cancer; the challenge is that a small number will, and those are the patients most likely to be missed if the threshold for re-evaluation is too high.
A single sentence captures the cost of delayed suspicion: spinal involvement changed Callum’s life before his cancer was even properly recognized.
McNulty said she now wants people to “go rule out cancer first” rather than leaving it until the end of the diagnostic process. That plea reflects a common failure mode in medicine, where reassuring explanations accumulate because they are plausible and familiar. A sports injury sounds reasonable in an active teenager. It can also be wrong.
Family advocacy now shapes how clinicians and parents respond
Callum and his family were supported through treatment by CLIC Sargent Jersey, and McNulty later became an ambassador for the charity. Case worker Tess Watson described her as someone whose strength has helped her speak to more families than the charity might otherwise reach directly. In that sense, one family’s experience has become a form of public health education.
Watson also said parents are now more engaged in conversations with their children about symptoms, and more willing to take concerns to general practice. That matters because parental instinct often becomes the first filter before a child reaches specialist care. When a parent notices that a child is not moving normally, is losing weight, is persistently unwell, or does not seem quite right, the family can become the difference between watchful waiting and a timely workup.
For oncology services, cases like Callum’s reinforce the need to keep rare cancers on the radar even when the presentation is ordinary on the surface. Pediatric and adolescent cancers can mimic musculoskeletal injury, viral illness, or routine fatigue. If symptoms do not improve as expected, the next step should be reassessment rather than complacency.
Rare cancers demand earlier suspicion, not later regret
There is no suggestion that every case of pain should trigger an immediate cancer diagnosis. The reality is more demanding than that. Clinicians need to hold two ideas at once: most symptoms in young people are benign, and some serious diseases hide behind those same symptoms until damage has already occurred.
Callum’s experience shows how much harm can follow when that balance tilts too far toward reassurance. His tumour had already reached the spine before discovery, and the consequences extended far beyond chemotherapy alone. For his mother, the enduring question is whether earlier recognition could have reduced the paralysis and the rehabilitation he had to endure.
Her campaign now centers on a simple clinical instruction: do not rule out cancer last when a young person has symptoms that persist or do not fit a straightforward explanation. In oncology, time can alter function, not just prognosis. In Callum’s case, it altered how he walked, how he recovered, and how his family remembers the years before his death.